Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec
Open Access
- 7 December 2017
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 36 (3), 421-426
- https://doi.org/10.1016/j.vaccine.2017.11.054
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Interim results of an ecological experiment - Conjugate vaccination against the pneumococcus and serotype replacementHuman Vaccines & Immunotherapeutics, 2016
- Indirect cohort analysis of 10-valent pneumococcal conjugate vaccine effectiveness against vaccine-type and vaccine-related invasive pneumococcal diseaseVaccine, 2015
- Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, CanadaVaccine, 2015
- Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control studyThe Lancet Respiratory Medicine, 2014
- Impact of 2+1 pneumococcal conjugate vaccine program in the province of Quebec, CanadaVaccine, 2014
- Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012Canadian Journal of Microbiology, 2013
- Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing scheduleVaccine, 2013
- Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance SitesPLoS Medicine, 2013
- Uptake of Pneumococcal Conjugate Vaccine: Methodological Issues in Measurement and Impact of Publicly Funded ProgramsCanadian Journal of Public Health, 2009
- Epidemiological differences among pneumococcal serotypesThe Lancet Infectious Diseases, 2005